Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of panel testing in familial breast and ovarian cancer.

Clinical medicine (London, England) - 1 Dec 2017

Prapa Matina, Solomons Joyce, Tischkowitz Marc

Abstract excerpt

Advances in sequencing technology have led to the introduction of panel testing in hereditary breast and ovarian cancer. While direct-to-consumer testing services have become widely available, the clinical validity of many of the genes on panel tests remains contentious and risk management guidelines are often lacking. This article gives an overview of advantages with panel testing as well as important...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AMP-Activated Protein Kinase Kinases
Share to Epithelial Cell Adhesion Molecule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Li-Fraumeni Syndrome

Share to MutL Protein Homolog 1

Share to MutS Homolog 2 Protein

Share to Peutz-Jeghers Syndrome

Share to PTEN Phosphohydrolase

Source

Open in PubMed Open full text

Identifiers

PMID: 29196360
DOI: 10.7861/clinmedicine.17-6-568
PMCID: PMC6297688

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of panel testing in familial breast and ovarian cancer.PMID 29196360Read ↗

Cancer risk assessment using genetic panel testing: considerations for clinical application.Semantic proximity Read ↗

Application of Panel-Based Tests for Inherited Risk of Cancer.Semantic proximity Read ↗

Routine use of gene panel testing in hereditary breast cancer should be performed with caution.Semantic proximity Read ↗

Panel testing for inherited susceptibility to breast, ovarian, and colorectal cancer.Semantic proximity Read ↗

Gene panel testing for inherited cancer risk.Semantic proximity Read ↗

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.Semantic proximity Read ↗

Genetic testing today.Semantic proximity Read ↗

Update on multi-gene panel testing and communication of genetic test results.Semantic proximity Read ↗

Multi gene panel testing for hereditary breast cancer - is it ready to be used?Semantic proximity Read ↗

Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.Semantic proximity Read ↗

Should all patients undergoing genetic testing for hereditary breast cancer syndromes be offered a multigene panel?Semantic proximity Read ↗

A Life Potentially Saved Through Hereditary Cancer Panel Testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.